发表期刊：Journal of Complementary and Integrative Medicine

发表时间：2026

Abstract:

Methods

A549 cells were cultured and allocated into two groups: treated with Peruvoside and an untreated control group. Viability of A549 cells was assessed by WST-8 assay; cell cycle analysis was performed by flow cytometry; CDK6 and cyclin D1 protein expression was determined by Western blot; and real-time PCR analysis was performed to identify the expression of CHK1, CHK2, PI3K, AKT, and mTOR genes.

Results

Peruvoside at a concentration of 68.77 nM was associated with a notable anti-proliferative effect and the induction of an apoptotic cascade. Peruvoside induces cell cycle arrest at the G2/M phase, validated by Western blot and real-time PCR analysis, confirming that inhibition of proteins and genes related to cell cycle progression and expansion of the lung cancer, indicating that Peruvoside has antiproliferative and pro-apoptotic effects.

Conclusions

Within this research, the data showed the arrest of the cell cycle and the inhibition of the proliferation regulatory gene by Peruvoside were associated with suppression of lung cancer survival, proliferation, metastatic dissemination, and promotion of cell death.

https://doi.org/10.1515/jcim-2026-0096